Time to treatment intensification with GLP-1 receptor agonists for patients with type 2 diabetes in the UK: medical record review study

被引：0
|
作者：
Norrbacka, K. [1 ]
Stein, D. [2 ]
Matza, L. S. [3 ]
Jordan, J. B. [3 ]
Garcia-Perez, L. -E. [4 ]
Hassan, S. W. [4 ]
Boye, K. S. [4 ]
机构：
[1] Eli Lilly Finland, Helsinki, Finland
[2] Evidera, London, England
[3] Evidera, Bethesda, MD USA
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
746
引用
收藏
页码：S363 / S364
页数：2
相关论文
共 50 条
  • [21] The GLP-1 Receptor Agonists Are Cost-Effective for the Treatment of Type 2 Diabetes
    Plodkowski, Raymond
    AMERICAN HEALTH AND DRUG BENEFITS, 2017, 10 (04): : 187 - 188
  • [22] GLP-1 receptor agonists in the treatment of type 2 diabetes-state-of-the-art
    Nauck, Michael A.
    Quast, Daniel R.
    Wefers, Jakob
    Meier, Juris J.
    MOLECULAR METABOLISM, 2020, 46
  • [23] Rationale Use of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes
    Jeff Unger
    Current Diabetes Reports, 2013, 13 : 663 - 668
  • [24] GASTROPARESIS RISK IN PATIENTS WITH TYPE 2 DIABETES PRESCRIBED GLP-1 RECEPTOR AGONISTS
    Qapaja, Thabet
    Hamid, Osama
    Abu-Rumaileh, Mohammed
    Kaya, Gizem
    Saleh, Sherif
    Garg, Samita
    GASTROENTEROLOGY, 2024, 166 (05) : S204 - S204
  • [25] Cardiovascular Effects of Different GLP-1 Receptor Agonists in Patients with Type 2 Diabetes
    Bahtiyar, Gul
    Pujals-Kury, Jean
    Sacerdote, Alan
    CURRENT DIABETES REPORTS, 2018, 18 (10)
  • [26] Cardiovascular Effects of Different GLP-1 Receptor Agonists in Patients with Type 2 Diabetes
    Gül Bahtiyar
    Jean Pujals-Kury
    Alan Sacerdote
    Current Diabetes Reports, 2018, 18
  • [27] Rationale Use of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes
    Unger, Jeff
    CURRENT DIABETES REPORTS, 2013, 13 (05) : 663 - 668
  • [28] Effectiveness and Safety of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes
    Almohareb, Sumaya N.
    Alfayez, Osamah M.
    Aljuaid, Shoroq S.
    Alshahrani, Walaa A.
    Bakhsh, Ghalia
    Alshammari, Mohammed K.
    Al Yami, Majed S.
    Alshaya, Omar A.
    Alomran, Abdullah S.
    Korayem, Ghazwa B.
    Almohammed, Omar A.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (21)
  • [29] An overview of new GLP-1 receptor agonists for type 2 diabetes
    Tomlinson, Brian
    Hu, Miao
    Zhang, Yuzhen
    Chan, Paul
    Liu, Zhong-Min
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (02) : 145 - 158
  • [30] GLP-1 receptor agonists and basal insulin in type 2 diabetes
    Young, Laura A.
    Buse, John B.
    LANCET, 2014, 384 (9961): : 2180 - 2181
12345